Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-10.2%
5Y CAGR+22.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-10.2%/yr
Annual compound
5Y CAGR
+22.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $45.93M | -15.5% |
| 2024 | $54.34M | -16.8% |
| 2023 | $65.28M | +2.9% |
| 2022 | $63.45M | +16.8% |
| 2021 | $54.32M | +219.4% |
| 2020 | $17.01M | -39.4% |
| 2019 | $28.04M | - |